Psilocybin Receives Breakthrough Status by the FDA for Depression

magic mushrooms receives breakthrough status from the fda

magic mushrooms receives breakthrough status from the fda

In November 2019, the US Food and Drug Administration (FDA) granted psilocybin therapy a breakthrough status for depression. This recognition makes it the second time in a year the FDA would designate such a status to psilocybin, the hallucinogenic compound in psychedelic mushrooms. The FDA’s action is meant to fast-track the typical slow process of drug development and review. Breakthrough status recognition is typically requested and granted only when there is preliminary evidence that suggests a therapy has the potential to provide a substantial improvement over already available therapy.

Breakthrough Status for Psilocybin Research by COMPASS Pathways

In October 2018, the FDA granted Breakthrough Therapy status to psilocybin therapy in the ongoing clinical trials being conducted by a British life sciences organization, COMPASS Pathways. COMPASS is investigating the potential of the psychoactive compound in magic mushrooms effect on treatment-resistant depression (TRD). TRD refers to a type of depression that has defied other treatment options tried by a patient. Specifically, the clinical trial by COMPASS focuses on patients suffering from Major Depressive Disorder (MDD) who haven’t responded well to at least two different antidepressants treatments. An estimated 10% to 30% of MDD patients suffer from this type of TRD.

Breakthrough Status for Psilocybin Research by Usona

This time around, the latest FDA’s breakthrough therapy status is for a clinical trial by a US-based organization, Usona Institute. The Usona’s work focuses on treating MDD patients with a single dose of psilocybin. It is narrowed down to patients who experience episodes of severe depression that last for more than two weeks. According to a statement from Usona Institute, more than 17 million people across the world experience this type of depression. The company further stated that psilocybin has the potential to profoundly impact the brain and wipe away depressive symptoms, thereby leading to a long-lasting benefit.

With more than 300 people across the globe suffering from depression, this groundbreaking potential by psilocybin could signal a significant milestone in the treatment of depression, which is also the world’s leading cause of disability. According to Dr Charles Raison, the director of clinical and translational research at Usona, the groundbreaking FDA’s acknowledgement shows that MDD “represents an unmet medical need and that the available data suggest that psilocybin may offer a substantial clinical improvement over existing therapies.”

Breakthrough Status to Fast-Track the Next Phase

With this designated status, phase 2 of this work by Usona is expected to complete by early 2021. This will also propel the trial to move quickly to its phase 3 trial, going by the past occurrences in previous therapies that received such recognition. Around one-third of treatments that previously received a Breakthrough Therapy status have progressed on to get market approval.

Phase 2 of the Usonal’s research plans to enroll 80 participants where each person will receive either a single dose of psilocybin or a placebo containing niacin. This method is quite similar to other psilocybin studies. And as the trial progresses, there would be a broader perspective on the efficacy of this psychedelic agent in treating the depressive disorder with a single dose, compared to other work focusing on treating depression with multiple doses.

Psychedelics: A Potential Game-Changer for Depression Treatment

It is worth noting also that this is not the first time a psychedelic substance would receive such a laudable recognition by the FDA. In March 2019, the FDA approved ketamine nasal sprays for the treatment of treatment-resistant depression. With these recent achievements, there is a possibility that psilocybin and other psychedelics could be a game-changer in the treatment of depression and other emotional sufferings.



  1. It’s remarkable to go to see this website and reading the views of all mates on the topic of this piece of writing, while I am also
    zealous of getting knowledge.

  2. My spouse and I stumbled over here coming from a different web address and thought I might as well check things
    out. I like what I see so i am just following you. Look forward to
    finding out about your web page repeatedly.

  3. Hi! Do you use Twitter? I’d like to follow you if that
    would be okay. I’m absolutely enjoying your blog and look forward to new updates.

    1. Yes we do! Thanks for supporting.

  4. I quite like reading a post that will make people think.
    Also, thanks for allowing for me to comment!

  5. Do you mind if I quote a few of your articles as long as I
    provide credit and sources back to your website? My blog is in the exact same area of interest as yours and
    my users would truly benefit from a lot of the information you present here.
    Please let me know if this okay with you. Appreciate

    Feel free to surf to my site; cbd for sleep

  6. Hi there! This post couldn’t be written any better! Looking through this article reminds me of my previous roommate!

    He always kept talking about this. I am going to send this
    article to him. Pretty sure he’s going to have a great read.
    Thanks for sharing!

    Here is my homepage best CBD for dogs

  7. Thanks again for the article. Really Cool.

  8. I will recommend your beautiful post site to my friends

  9. Thanks a lot for the blog article. Really looking forward to read more. Fantastic. Harmony Othello Reiner

  10. I enjoyed reading a very successful article

  11. […] much so that the Food and Drug Administration (FDA) granted psilocybin therapy breakthrough status for […]

  12. I am genuinely grateful to the holder of this site who has shared this wonderful article at at this time. Odilia Stephen Nations

  13. I am so grateful for your blog post. Much thanks again. Awesome. Daphne Gregoor Haff

  14. I loved your blog.Really looking forward to read more. Will read on…

  15. Thanks again for the article. Really Cool.

  16. I loved your blog.Really looking forward to read more. Will read on…

  17. I must say I read a great article with pleasure

  18. Very informative blog article.Much thanks again. Fantastic.

  19. I will recommend your beautiful post site to my friends

  20. I love surfing on your pleasant site

  21. I value the blog article.Really looking forward to read more. Will read on… Chauncey Shortell

  22. I really like what you guys tend to be up too. This type of clever work and reporting! Keep up the amazing works guys I’ve included you guys to our blogroll. Sammie Clowes

  23. I loved your post.Really thank you! Great. Aurelio Zeiss

  24. Merely wanna comment on few general things, The website design is perfect, the subject matter is rattling fantastic : D. Maitilde Forrester Rochella

  25. I am so grateful for your blog article. Keep writing. Wandie Ambros Frangos

  26. Sweet web site, super design and style, very clean and employ pleasant. Carlee Brnaba Johannes

  27. I am really inspired with your writing skills and also with the format to your blog. Jackqueline Dov Rolfe

  28. Thanks a lot! This is definitely an very good webpage. Jane Constantin Kinelski

  29. You made some fine points there. I did a search on the issue and found nearly all persons will have the same opinion with your blog. Pamela Stanley Oman

  30. erotik izle

    I value the details on your internet site. Many thanks. Dana Teador Viking

  31. You got a very excellent website, Gladiolus I observed it through yahoo. Norma Patsy Justus

  32. Way cool! Some very valid points! I appreciate you writing this article and the rest of the site is also really good. Kristina Olin Rigby

  33. What a stuff of un-ambiguity and preserveness of precious knowledge regarding unexpected feelings. Micki Coleman Thrift

  34. Jacquelyn Loy Deirdre

    There is certainly a great deal to know about this subject. I like all of the points you have made.

Leave a Reply
    Your Cart
    Your cart is empty
      Calculate Shipping
      Apply Coupon